Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy

Radionuclide therapy aims to treat malignant diseases by systemic administration of radiopharmaceuticals, often using carrier molecules such as peptides and antibodies. The radionuclides used emit electrons or alpha particles as a consequence of radioactive decay, thus leading to local energy deposi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungberg, Michael, Sjögreen Gleisner, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665601/
https://www.ncbi.nlm.nih.gov/pubmed/26854156
http://dx.doi.org/10.3390/diagnostics5030296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665601/
https://www.ncbi.nlm.nih.gov/pubmed/26854156
http://dx.doi.org/10.3390/diagnostics5030296

Ejemplares similares